248 related articles for article (PubMed ID: 12400131)
1. [Betaserc treatment of acute disorders of cerebral circulation with vestibulo-ataxic and cochleo-vestibular syndromes].
Berdichevskiĭ MIa; Karmirian SA; Geĭko II; Miroshnichenko VE; Parkhaeva TN; Popova VG; Timchenko LV; Filina TV; Aristova LA
Vestn Otorinolaringol; 2002; (4):32-3. PubMed ID: 12400131
[No Abstract] [Full Text] [Related]
2. [Future treatment of stroke. Brain damage in stroke can be reduced by drugs].
Siesjö BK
Lakartidningen; 1993 Sep; 90(36):2958, 2962-4. PubMed ID: 8366724
[No Abstract] [Full Text] [Related]
3. [Use of seduxen to arrest acute cochleovestibular syndromes in transient cerebral disorders].
Bakhur VT; Zaikin VS; Voronin TS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1134-7. PubMed ID: 696100
[TBL] [Abstract][Full Text] [Related]
4. [A use of betaserc in ataxic syndromes].
Prokopenko SV; Rudnev VA; Afanas'eva EV; Abramov VG
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(8):41-5. PubMed ID: 15554141
[TBL] [Abstract][Full Text] [Related]
5. [Hemodynamic disturbances and the means for their pharmacological correction in transient disorders of cerebral circulation and ischemic stroke].
Vinichuk SM
Vrach Delo; 1986 Feb; (2):37-41. PubMed ID: 3705565
[No Abstract] [Full Text] [Related]
6. Orally administered betahistine and regional cerebral blood flow in cerebrovascular disease.
Meyer JS; Mathew NT; Hartmann A; Rivera VM
J Clin Pharmacol; 1974; 14(5-6):280-9. PubMed ID: 4208360
[No Abstract] [Full Text] [Related]
7. [Therapeutic approach to TIA and acute cerebral stroke in geriatric patients using a platelet aggregation inhibiting and vasoactive drug].
Cucinotta D; Monica C; Silvestrini C; Ceccato S; Cocchi C
G Clin Med; 1979 Apr; 60(4):301-9. PubMed ID: 488589
[No Abstract] [Full Text] [Related]
8. Reevaluating obstructive sleep apnea as a risk factor for cerebrovascular disease.
Attarian H
J Stroke Cerebrovasc Dis; 2010; 19(5):337-9. PubMed ID: 20816348
[No Abstract] [Full Text] [Related]
9. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
Pekaskiĭ SI
Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
[TBL] [Abstract][Full Text] [Related]
10. Compendium of cerebrovascular diseases.
Rafii MS; Hillis AE
Int Rev Psychiatry; 2006 Oct; 18(5):395-407. PubMed ID: 17085359
[TBL] [Abstract][Full Text] [Related]
11. [The role of betaserk in combined treatment of neurosensory hypoacusis and vestibulopathy in childhood].
Chistiakova VR
Vestn Otorinolaringol; 2004; (2):9-12. PubMed ID: 15111941
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of betahistine for the prevention of seasickness: effect on vestibular function, psychomotor performance and efficacy at sea.
Gordon CR; Doweck I; Nachum Z; Gonen A; Spitzer O; Shupak A
J Vestib Res; 2003; 13(2-3):103-11. PubMed ID: 14757913
[TBL] [Abstract][Full Text] [Related]
13. Ischemic stroke syndromes: classification, pathophysiology and clinical features.
Stone WM
Med Health R I; 1998 Jun; 81(6):197-203. PubMed ID: 9654896
[No Abstract] [Full Text] [Related]
14. [Treatment of ischemic brain lesions].
Eichhorn O
Med Welt; 1969 Oct; 42():2314-8. PubMed ID: 4982284
[No Abstract] [Full Text] [Related]
15. Sleep disorderd breathing and recurrence of cerebrovascular events, case-fatality, and functional outcome in patients with ischemic stroke or transient ischemic attack.
Rola R; Jarosz H; Wierzbicka A; Wichniak A; Richter P; Ryglewicz D; Jernajczyk W
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():615-21. PubMed ID: 19218688
[TBL] [Abstract][Full Text] [Related]
16. [Vincamine in the treatment of minor ictus (due to transient cerebral ischemia)].
Franzini C; Ferrante P
Minerva Med; 1974 Apr; 65(29):1631-41. PubMed ID: 4599654
[No Abstract] [Full Text] [Related]
17. [The use of betaserk in patients with cochlear-vestibular disorders].
Kadymov MI; Poliakova TS; Vladimirova TN
Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
[TBL] [Abstract][Full Text] [Related]
18. Histamine and betahistine in the treatment of vertigo: elucidation of mechanisms of action.
Lacour M; Sterkers O
CNS Drugs; 2001; 15(11):853-70. PubMed ID: 11700150
[TBL] [Abstract][Full Text] [Related]
19. New treatments for acute stroke.
Schehr RS
Nat Biotechnol; 1996 Nov; 14(11):1549-54. PubMed ID: 9634819
[No Abstract] [Full Text] [Related]
20. [The new cerebrovascular preparation pikamilon].
Mirzoian RS; Gan'shina TS
Farmakol Toksikol; 1989; 52(1):23-6. PubMed ID: 2707413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
